In patients who may very well be at risk of intracranial effects of CO2 retention (e.g., Individuals with evidence of improved intracranial force or Mind tumors), therapy could lessen respiratory push, and resultant CO2 retention can more improve intracranial strain; watch these individuals for signs of sedation and respiratory depression, https://wockusa.com/product/akorn-promethazine-hydrochloride-and-codeine-phosphate-solution/